nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—Interstitial pneumonia—Etoposide—uterine cancer	0.00971	0.00971	CcSEcCtD
Penicillamine—Proteinuria—Medroxyprogesterone Acetate—uterine cancer	0.00946	0.00946	CcSEcCtD
Penicillamine—Protein urine present—Medroxyprogesterone Acetate—uterine cancer	0.00933	0.00933	CcSEcCtD
Penicillamine—Leukaemia—Doxorubicin—uterine cancer	0.00904	0.00904	CcSEcCtD
Penicillamine—Leukocytosis—Medroxyprogesterone Acetate—uterine cancer	0.00885	0.00885	CcSEcCtD
Penicillamine—Coagulopathy—Dactinomycin—uterine cancer	0.00833	0.00833	CcSEcCtD
Penicillamine—Lymphadenopathy—Progesterone—uterine cancer	0.00781	0.00781	CcSEcCtD
Penicillamine—Thrombophlebitis—Progesterone—uterine cancer	0.00769	0.00769	CcSEcCtD
Penicillamine—Optic neuritis—Etoposide—uterine cancer	0.00763	0.00763	CcSEcCtD
Penicillamine—Hepatic function abnormal—Progesterone—uterine cancer	0.00762	0.00762	CcSEcCtD
Penicillamine—Mouth ulceration—Medroxyprogesterone Acetate—uterine cancer	0.00752	0.00752	CcSEcCtD
Penicillamine—Extravasation—Dactinomycin—uterine cancer	0.00743	0.00743	CcSEcCtD
Penicillamine—Hepatic failure—Progesterone—uterine cancer	0.00741	0.00741	CcSEcCtD
Penicillamine—Injury—Progesterone—uterine cancer	0.00725	0.00725	CcSEcCtD
Penicillamine—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.00697	0.00697	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Medroxyprogesterone Acetate—uterine cancer	0.00694	0.00694	CcSEcCtD
Penicillamine—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00691	0.00691	CcSEcCtD
Penicillamine—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00672	0.00672	CcSEcCtD
Penicillamine—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00669	0.00669	CcSEcCtD
Penicillamine—Interstitial lung disease—Etoposide—uterine cancer	0.00663	0.00663	CcSEcCtD
Penicillamine—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00618	0.00618	CcSEcCtD
Penicillamine—Aplastic anaemia—Dactinomycin—uterine cancer	0.00609	0.00609	CcSEcCtD
Penicillamine—Mouth ulceration—Dactinomycin—uterine cancer	0.00586	0.00586	CcSEcCtD
Penicillamine—Asthma—Progesterone—uterine cancer	0.00576	0.00576	CcSEcCtD
Penicillamine—Extravasation—Etoposide—uterine cancer	0.00538	0.00538	CcSEcCtD
Penicillamine—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00532	0.00532	CcSEcCtD
Penicillamine—Hepatic failure—Dactinomycin—uterine cancer	0.00524	0.00524	CcSEcCtD
Penicillamine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00522	0.00522	CcSEcCtD
Penicillamine—Neuropathy peripheral—Progesterone—uterine cancer	0.00503	0.00503	CcSEcCtD
Penicillamine—Body temperature increased—Carboplatin—uterine cancer	0.00493	0.00493	CcSEcCtD
Penicillamine—Hepatobiliary disease—Progesterone—uterine cancer	0.00485	0.00485	CcSEcCtD
Penicillamine—Haemoglobin—Progesterone—uterine cancer	0.00463	0.00463	CcSEcCtD
Penicillamine—Haemorrhage—Progesterone—uterine cancer	0.00461	0.00461	CcSEcCtD
Penicillamine—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00456	0.00456	CcSEcCtD
Penicillamine—Urinary tract disorder—Progesterone—uterine cancer	0.00455	0.00455	CcSEcCtD
Penicillamine—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00453	0.00453	CcSEcCtD
Penicillamine—Urethral disorder—Progesterone—uterine cancer	0.00452	0.00452	CcSEcCtD
Penicillamine—Neuropathy—Etoposide—uterine cancer	0.00441	0.00441	CcSEcCtD
Penicillamine—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.0044	0.0044	CcSEcCtD
Penicillamine—Tinnitus—Progesterone—uterine cancer	0.0043	0.0043	CcSEcCtD
Penicillamine—Eruption—Epirubicin—uterine cancer	0.00428	0.00428	CcSEcCtD
Penicillamine—Optic neuritis—Epirubicin—uterine cancer	0.00428	0.00428	CcSEcCtD
Penicillamine—Mouth ulceration—Etoposide—uterine cancer	0.00424	0.00424	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00424	0.00424	CcSEcCtD
Penicillamine—Thrombocytosis—Epirubicin—uterine cancer	0.00423	0.00423	CcSEcCtD
Penicillamine—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.0042	0.0042	CcSEcCtD
Penicillamine—Angiopathy—Progesterone—uterine cancer	0.00418	0.00418	CcSEcCtD
Penicillamine—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00418	0.00418	CcSEcCtD
Penicillamine—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00412	0.00412	CcSEcCtD
Penicillamine—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00409	0.00409	CcSEcCtD
Penicillamine—Alopecia—Progesterone—uterine cancer	0.00407	0.00407	CcSEcCtD
Penicillamine—Mental disorder—Progesterone—uterine cancer	0.00404	0.00404	CcSEcCtD
Penicillamine—Eruption—Doxorubicin—uterine cancer	0.00396	0.00396	CcSEcCtD
Penicillamine—Optic neuritis—Doxorubicin—uterine cancer	0.00396	0.00396	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Etoposide—uterine cancer	0.00392	0.00392	CcSEcCtD
Penicillamine—Thrombocytosis—Doxorubicin—uterine cancer	0.00391	0.00391	CcSEcCtD
Penicillamine—Bone marrow depression—Epirubicin—uterine cancer	0.0039	0.0039	CcSEcCtD
Penicillamine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00389	0.00389	CcSEcCtD
Penicillamine—Pancytopenia—Dactinomycin—uterine cancer	0.00386	0.00386	CcSEcCtD
Penicillamine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00379	0.00379	CcSEcCtD
Penicillamine—Anaemia—Progesterone—uterine cancer	0.00371	0.00371	CcSEcCtD
Penicillamine—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00369	0.00369	CcSEcCtD
Penicillamine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00366	0.00366	CcSEcCtD
Penicillamine—Bone marrow depression—Doxorubicin—uterine cancer	0.00361	0.00361	CcSEcCtD
Penicillamine—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00356	0.00356	CcSEcCtD
Penicillamine—Stomatitis—Dactinomycin—uterine cancer	0.00354	0.00354	CcSEcCtD
Penicillamine—Rash erythematous—Epirubicin—uterine cancer	0.00344	0.00344	CcSEcCtD
Penicillamine—Arthralgia—Progesterone—uterine cancer	0.00341	0.00341	CcSEcCtD
Penicillamine—Anxiety—Progesterone—uterine cancer	0.0034	0.0034	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00339	0.00339	CcSEcCtD
Penicillamine—Agranulocytosis—Dactinomycin—uterine cancer	0.00339	0.00339	CcSEcCtD
Penicillamine—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00336	0.00336	CcSEcCtD
Penicillamine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00334	0.00334	CcSEcCtD
Penicillamine—Ageusia—Epirubicin—uterine cancer	0.00325	0.00325	CcSEcCtD
Penicillamine—Skin disorder—Progesterone—uterine cancer	0.00318	0.00318	CcSEcCtD
Penicillamine—Rash erythematous—Doxorubicin—uterine cancer	0.00318	0.00318	CcSEcCtD
Penicillamine—Anorexia—Progesterone—uterine cancer	0.00312	0.00312	CcSEcCtD
Penicillamine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00309	0.00309	CcSEcCtD
Penicillamine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00308	0.00308	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00307	0.00307	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00307	0.00307	CcSEcCtD
Penicillamine—Extravasation—Epirubicin—uterine cancer	0.00302	0.00302	CcSEcCtD
Penicillamine—Ageusia—Doxorubicin—uterine cancer	0.003	0.003	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00298	0.00298	CcSEcCtD
Penicillamine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.0029	0.0029	CcSEcCtD
Penicillamine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00288	0.00288	CcSEcCtD
Penicillamine—Alopecia—Dactinomycin—uterine cancer	0.00288	0.00288	CcSEcCtD
Penicillamine—Glossitis—Epirubicin—uterine cancer	0.00286	0.00286	CcSEcCtD
Penicillamine—Decreased appetite—Progesterone—uterine cancer	0.00285	0.00285	CcSEcCtD
Penicillamine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00283	0.00283	CcSEcCtD
Penicillamine—Pancytopenia—Etoposide—uterine cancer	0.0028	0.0028	CcSEcCtD
Penicillamine—Extravasation—Doxorubicin—uterine cancer	0.00279	0.00279	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.0027	CcSEcCtD
Penicillamine—Glossitis—Doxorubicin—uterine cancer	0.00264	0.00264	CcSEcCtD
Penicillamine—Anaemia—Dactinomycin—uterine cancer	0.00262	0.00262	CcSEcCtD
Penicillamine—Urticaria—Progesterone—uterine cancer	0.0026	0.0026	CcSEcCtD
Penicillamine—Body temperature increased—Progesterone—uterine cancer	0.00259	0.00259	CcSEcCtD
Penicillamine—Renal failure—Etoposide—uterine cancer	0.00258	0.00258	CcSEcCtD
Penicillamine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00258	CcSEcCtD
Penicillamine—Neuropathy peripheral—Etoposide—uterine cancer	0.00257	0.00257	CcSEcCtD
Penicillamine—Stomatitis—Etoposide—uterine cancer	0.00256	0.00256	CcSEcCtD
Penicillamine—Leukopenia—Dactinomycin—uterine cancer	0.00254	0.00254	CcSEcCtD
Penicillamine—Hepatobiliary disease—Etoposide—uterine cancer	0.00248	0.00248	CcSEcCtD
Penicillamine—Aplastic anaemia—Epirubicin—uterine cancer	0.00247	0.00247	CcSEcCtD
Penicillamine—Neuropathy—Epirubicin—uterine cancer	0.00247	0.00247	CcSEcCtD
Penicillamine—Agranulocytosis—Etoposide—uterine cancer	0.00245	0.00245	CcSEcCtD
Penicillamine—Hypersensitivity—Progesterone—uterine cancer	0.00241	0.00241	CcSEcCtD
Penicillamine—Mouth ulceration—Epirubicin—uterine cancer	0.00238	0.00238	CcSEcCtD
Penicillamine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00236	0.00236	CcSEcCtD
Penicillamine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00234	CcSEcCtD
Penicillamine—Urinary tract disorder—Etoposide—uterine cancer	0.00233	0.00233	CcSEcCtD
Penicillamine—Urethral disorder—Etoposide—uterine cancer	0.00231	0.00231	CcSEcCtD
Penicillamine—Aplastic anaemia—Doxorubicin—uterine cancer	0.00229	0.00229	CcSEcCtD
Penicillamine—Neuropathy—Doxorubicin—uterine cancer	0.00229	0.00229	CcSEcCtD
Penicillamine—Thrombocytopenia—Dactinomycin—uterine cancer	0.00227	0.00227	CcSEcCtD
Penicillamine—Diarrhoea—Progesterone—uterine cancer	0.00224	0.00224	CcSEcCtD
Penicillamine—Lymphadenopathy—Epirubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Penicillamine—Thrombophlebitis—Epirubicin—uterine cancer	0.00221	0.00221	CcSEcCtD
Penicillamine—Anorexia—Dactinomycin—uterine cancer	0.00221	0.00221	CcSEcCtD
Penicillamine—Mouth ulceration—Doxorubicin—uterine cancer	0.0022	0.0022	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.0022	0.0022	CcSEcCtD
Penicillamine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00219	CcSEcCtD
Penicillamine—Hepatic function abnormal—Epirubicin—uterine cancer	0.00219	0.00219	CcSEcCtD
Penicillamine—Angiopathy—Etoposide—uterine cancer	0.00214	0.00214	CcSEcCtD
Penicillamine—Hepatic failure—Epirubicin—uterine cancer	0.00213	0.00213	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00211	0.00211	CcSEcCtD
Penicillamine—Alopecia—Etoposide—uterine cancer	0.00208	0.00208	CcSEcCtD
Penicillamine—Vomiting—Progesterone—uterine cancer	0.00208	0.00208	CcSEcCtD
Penicillamine—Lymphadenopathy—Doxorubicin—uterine cancer	0.00207	0.00207	CcSEcCtD
Penicillamine—Rash—Progesterone—uterine cancer	0.00206	0.00206	CcSEcCtD
Penicillamine—Dermatitis—Progesterone—uterine cancer	0.00206	0.00206	CcSEcCtD
Penicillamine—Thrombophlebitis—Doxorubicin—uterine cancer	0.00204	0.00204	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.00203	0.00203	CcSEcCtD
Penicillamine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.00203	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00202	0.00202	CcSEcCtD
Penicillamine—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00202	0.00202	CcSEcCtD
Penicillamine—Decreased appetite—Dactinomycin—uterine cancer	0.00201	0.00201	CcSEcCtD
Penicillamine—Dysgeusia—Etoposide—uterine cancer	0.00201	0.00201	CcSEcCtD
Penicillamine—Hepatic failure—Doxorubicin—uterine cancer	0.00197	0.00197	CcSEcCtD
Penicillamine—Hypoglycaemia—Epirubicin—uterine cancer	0.00196	0.00196	CcSEcCtD
Penicillamine—Nausea—Progesterone—uterine cancer	0.00194	0.00194	CcSEcCtD
Penicillamine—Anaemia—Etoposide—uterine cancer	0.0019	0.0019	CcSEcCtD
Penicillamine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00189	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00187	0.00187	CcSEcCtD
Penicillamine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.00187	CcSEcCtD
Penicillamine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.00187	CcSEcCtD
Penicillamine—Leukopenia—Etoposide—uterine cancer	0.00184	0.00184	CcSEcCtD
Penicillamine—Body temperature increased—Dactinomycin—uterine cancer	0.00183	0.00183	CcSEcCtD
Penicillamine—Hypoglycaemia—Doxorubicin—uterine cancer	0.00181	0.00181	CcSEcCtD
Penicillamine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00176	CcSEcCtD
Penicillamine—Abdominal pain upper—Epirubicin—uterine cancer	0.00174	0.00174	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00173	0.00173	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00172	0.00172	CcSEcCtD
Penicillamine—Hypersensitivity—Dactinomycin—uterine cancer	0.0017	0.0017	CcSEcCtD
Penicillamine—Muscular weakness—Epirubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Penicillamine—Asthma—Epirubicin—uterine cancer	0.00165	0.00165	CcSEcCtD
Penicillamine—Thrombocytopenia—Etoposide—uterine cancer	0.00164	0.00164	CcSEcCtD
Penicillamine—Eosinophilia—Epirubicin—uterine cancer	0.00163	0.00163	CcSEcCtD
Penicillamine—Skin disorder—Etoposide—uterine cancer	0.00163	0.00163	CcSEcCtD
Penicillamine—Pancreatitis—Epirubicin—uterine cancer	0.00162	0.00162	CcSEcCtD
Penicillamine—Abdominal pain upper—Doxorubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Penicillamine—Anorexia—Etoposide—uterine cancer	0.0016	0.0016	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00159	0.00159	CcSEcCtD
Penicillamine—Diarrhoea—Dactinomycin—uterine cancer	0.00158	0.00158	CcSEcCtD
Penicillamine—Pancytopenia—Epirubicin—uterine cancer	0.00157	0.00157	CcSEcCtD
Penicillamine—Muscular weakness—Doxorubicin—uterine cancer	0.00156	0.00156	CcSEcCtD
Penicillamine—Asthma—Doxorubicin—uterine cancer	0.00153	0.00153	CcSEcCtD
Penicillamine—Eosinophilia—Doxorubicin—uterine cancer	0.00151	0.00151	CcSEcCtD
Penicillamine—Pancreatitis—Doxorubicin—uterine cancer	0.0015	0.0015	CcSEcCtD
Penicillamine—Vomiting—Dactinomycin—uterine cancer	0.00147	0.00147	CcSEcCtD
Penicillamine—Rash—Dactinomycin—uterine cancer	0.00146	0.00146	CcSEcCtD
Penicillamine—Decreased appetite—Etoposide—uterine cancer	0.00146	0.00146	CcSEcCtD
Penicillamine—Pancytopenia—Doxorubicin—uterine cancer	0.00145	0.00145	CcSEcCtD
Penicillamine—Renal failure—Epirubicin—uterine cancer	0.00145	0.00145	CcSEcCtD
Penicillamine—Neuropathy peripheral—Epirubicin—uterine cancer	0.00144	0.00144	CcSEcCtD
Penicillamine—Stomatitis—Epirubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Penicillamine—Haematuria—Epirubicin—uterine cancer	0.0014	0.0014	CcSEcCtD
Penicillamine—Hepatobiliary disease—Epirubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Penicillamine—Nausea—Dactinomycin—uterine cancer	0.00137	0.00137	CcSEcCtD
Penicillamine—Agranulocytosis—Epirubicin—uterine cancer	0.00137	0.00137	CcSEcCtD
Penicillamine—Renal failure—Doxorubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Penicillamine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.00133	0.00133	CcSEcCtD
Penicillamine—Urticaria—Etoposide—uterine cancer	0.00133	0.00133	CcSEcCtD
Penicillamine—Haemoglobin—Epirubicin—uterine cancer	0.00133	0.00133	CcSEcCtD
Penicillamine—Stomatitis—Doxorubicin—uterine cancer	0.00133	0.00133	CcSEcCtD
Penicillamine—Body temperature increased—Etoposide—uterine cancer	0.00132	0.00132	CcSEcCtD
Penicillamine—Haemorrhage—Epirubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Penicillamine—Urinary tract disorder—Epirubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Penicillamine—Haematuria—Doxorubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Penicillamine—Urethral disorder—Epirubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Penicillamine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00129	0.00129	CcSEcCtD
Penicillamine—Agranulocytosis—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Penicillamine—Hypersensitivity—Etoposide—uterine cancer	0.00123	0.00123	CcSEcCtD
Penicillamine—Tinnitus—Epirubicin—uterine cancer	0.00123	0.00123	CcSEcCtD
Penicillamine—Haemoglobin—Doxorubicin—uterine cancer	0.00123	0.00123	CcSEcCtD
Penicillamine—Haemorrhage—Doxorubicin—uterine cancer	0.00122	0.00122	CcSEcCtD
Penicillamine—Urinary tract disorder—Doxorubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Penicillamine—Angiopathy—Epirubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
Penicillamine—Urethral disorder—Doxorubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
Penicillamine—Alopecia—Epirubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Penicillamine—Mental disorder—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Penicillamine—Diarrhoea—Etoposide—uterine cancer	0.00115	0.00115	CcSEcCtD
Penicillamine—Tinnitus—Doxorubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Penicillamine—Dysgeusia—Epirubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Penicillamine—Angiopathy—Doxorubicin—uterine cancer	0.00111	0.00111	CcSEcCtD
Penicillamine—Alopecia—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Penicillamine—Mental disorder—Doxorubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Penicillamine—Vomiting—Etoposide—uterine cancer	0.00106	0.00106	CcSEcCtD
Penicillamine—Anaemia—Epirubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Penicillamine—Agitation—Epirubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Penicillamine—Rash—Etoposide—uterine cancer	0.00106	0.00106	CcSEcCtD
Penicillamine—Dermatitis—Etoposide—uterine cancer	0.00105	0.00105	CcSEcCtD
Penicillamine—Dysgeusia—Doxorubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Penicillamine—Leukopenia—Epirubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Penicillamine—Nausea—Etoposide—uterine cancer	0.000995	0.000995	CcSEcCtD
Penicillamine—Anaemia—Doxorubicin—uterine cancer	0.000984	0.000984	CcSEcCtD
Penicillamine—Arthralgia—Epirubicin—uterine cancer	0.000979	0.000979	CcSEcCtD
Penicillamine—Agitation—Doxorubicin—uterine cancer	0.000978	0.000978	CcSEcCtD
Penicillamine—Anxiety—Epirubicin—uterine cancer	0.000976	0.000976	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000972	0.000972	CcSEcCtD
Penicillamine—Leukopenia—Doxorubicin—uterine cancer	0.000953	0.000953	CcSEcCtD
Penicillamine—Thrombocytopenia—Epirubicin—uterine cancer	0.000919	0.000919	CcSEcCtD
Penicillamine—Skin disorder—Epirubicin—uterine cancer	0.000912	0.000912	CcSEcCtD
Penicillamine—Arthralgia—Doxorubicin—uterine cancer	0.000906	0.000906	CcSEcCtD
Penicillamine—Anxiety—Doxorubicin—uterine cancer	0.000903	0.000903	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.0009	0.0009	CcSEcCtD
Penicillamine—Anorexia—Epirubicin—uterine cancer	0.000895	0.000895	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000855	0.000855	CcSEcCtD
Penicillamine—Thrombocytopenia—Doxorubicin—uterine cancer	0.00085	0.00085	CcSEcCtD
Penicillamine—Skin disorder—Doxorubicin—uterine cancer	0.000844	0.000844	CcSEcCtD
Penicillamine—Anorexia—Doxorubicin—uterine cancer	0.000828	0.000828	CcSEcCtD
Penicillamine—Decreased appetite—Epirubicin—uterine cancer	0.000816	0.000816	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000791	0.000791	CcSEcCtD
Penicillamine—Decreased appetite—Doxorubicin—uterine cancer	0.000755	0.000755	CcSEcCtD
Penicillamine—Urticaria—Epirubicin—uterine cancer	0.000746	0.000746	CcSEcCtD
Penicillamine—Body temperature increased—Epirubicin—uterine cancer	0.000742	0.000742	CcSEcCtD
Penicillamine—Hypersensitivity—Epirubicin—uterine cancer	0.000692	0.000692	CcSEcCtD
Penicillamine—Urticaria—Doxorubicin—uterine cancer	0.00069	0.00069	CcSEcCtD
Penicillamine—Body temperature increased—Doxorubicin—uterine cancer	0.000687	0.000687	CcSEcCtD
Penicillamine—Diarrhoea—Epirubicin—uterine cancer	0.000642	0.000642	CcSEcCtD
Penicillamine—Hypersensitivity—Doxorubicin—uterine cancer	0.00064	0.00064	CcSEcCtD
Penicillamine—Vomiting—Epirubicin—uterine cancer	0.000597	0.000597	CcSEcCtD
Penicillamine—Diarrhoea—Doxorubicin—uterine cancer	0.000594	0.000594	CcSEcCtD
Penicillamine—Rash—Epirubicin—uterine cancer	0.000592	0.000592	CcSEcCtD
Penicillamine—Dermatitis—Epirubicin—uterine cancer	0.000591	0.000591	CcSEcCtD
Penicillamine—Nausea—Epirubicin—uterine cancer	0.000558	0.000558	CcSEcCtD
Penicillamine—Vomiting—Doxorubicin—uterine cancer	0.000552	0.000552	CcSEcCtD
Penicillamine—Rash—Doxorubicin—uterine cancer	0.000548	0.000548	CcSEcCtD
Penicillamine—Dermatitis—Doxorubicin—uterine cancer	0.000547	0.000547	CcSEcCtD
Penicillamine—Nausea—Doxorubicin—uterine cancer	0.000516	0.000516	CcSEcCtD
